Use of more costly diabetes medications varies widely
(HealthDay)—Even within an integrated Veterans Affairs (VA) system with a uniform national formulary and established criteria for drug use, there is substantial variation in the use of thiazolidinediones ...
Diabetes
Oct 12, 2012 |
not rated yet |
0
Study tests potential new drug to reduce pain and symptoms of endometriosis
(Medical Xpress)—According to the Centers for Disease Control (CDC), endometriosis, a gynecological disorder in which cells from the uterus lining grow in other areas of the body, is the number one reason for a hysterectomy ...
Obstetrics & gynaecology
Oct 09, 2012 |
not rated yet |
0
New evidence on easing inflammation of brain cells for Alzheimer's disease
New research proves the validity of one of the most promising approaches for combating Alzheimer's disease (AD) with medicines that treat not just some of the symptoms, but actually stop or prevent the disease ...
Alzheimer's disease & dementia
Oct 03, 2012 |
5 / 5 (1) |
0
Undertreatment of common heart condition persists despite rapid adoption of novel therapies
A novel blood thinner recently approved by the FDA, dabigatran (Pradaxa), has been rapidly adopted into clinical practice, yet thus far has had little impact on improving treatment rates for atrial fibrillation. This is according ...
Cardiology
Sep 21, 2012 |
not rated yet |
0
Children taking steroids for asthma are slightly shorter than peers
Children who use inhaled steroid drugs for asthma end up slightly shorter at their full adult height than children who don't use the drugs, new results from a comprehensive asthma study show.
Immunology
Sep 03, 2012 |
5 / 5 (1) |
1
|
Omission of aspirin from antiplatelet regimen: The WOEST study
Lifelong anticoagulation is necessary for the prevention of stroke in patients with rhythm disturbances and with mechanical valves. Patients who have a coronary stent implanted also need the antiplatelet drugs aspirin and ...
Cardiology
Aug 28, 2012 |
not rated yet |
0
Gonorrhea resistant to all but one antibiotic: CDC
(HealthDay) -- With options shrinking to a single antibiotic that can fight resistant strains of gonorrhea, U.S. health authorities issued revised guidelines for treating the sexually transmitted bacteria ...
Diseases, Conditions, Syndromes
Aug 09, 2012 |
5 / 5 (1) |
1
|
US approves first pill to help prevent HIV
(AP) The Food and Drug Administration on Monday approved the first drug shown to reduce the risk of HIV infection, the latest milestone in the 30-year battle against the virus that causes AIDS.
HIV & AIDS
Jul 16, 2012 |
4 / 5 (1) |
0
Medicare coverage gap associated with reductions in antidepressant use in study
The Medicare Part D coverage gap was associated with reduced use of antidepressants in a study of beneficiaries 65 years or older with depression, according to a report by Archives of General Psychiatry.
Psychology & Psychiatry
Jul 02, 2012 |
not rated yet |
0
Birth control that uses combined hormones raises heart risk: study
(HealthDay) -- Sweeping new research comparing various forms of hormonal contraception -- including birth control pills, vaginal rings and skin patches -- suggests that the risk for heart attacks and strokes ...
Medications
Jun 13, 2012 |
not rated yet |
1
|
Diabetes drug metformin may cut breast cancer risk in older women
(HealthDay) -- A widely prescribed drug, metformin, may lower the risk of invasive breast cancer in postmenopausal women with diabetes, a new study indicates.
Cancer
Jun 11, 2012 |
not rated yet |
0
Study shows benefit of new maintenance therapy for multiple myeloma
Multiple myeloma is a form of cancer where the plasma cells in the bone marrow grow out of control, causing damage to bones as well as predisposing patients to anemia, infection and kidney failure. A medical procedure called ...
Cancer
May 11, 2012 |
5 / 5 (1) |
0
|
FDA panel urges approval for Pfizer arthritis drug
An advisory committee to the US Food and Drug Administration on Wednesday urged US regulators to approve a new treatment for rheumatoid arthritis made by the pharmaceutical giant Pfizer.
Arthritis & Rheumatism
May 09, 2012 |
not rated yet |
0
Saliva test could dramatically increase detection of oral cancer
A Michigan State University surgeon is teaming up with a Lansing-area dental benefits firm on a clinical trial to create a simple, cost-effective saliva test to detect oral cancer, a breakthrough that would drastically improve ...
Cancer
Apr 17, 2012 |
not rated yet |
0
ONO-4641 pill reduced number of MS lesions in Phase II trial
An investigational oral drug called ONO-4641 reduced the number of lesions in people with multiple sclerosis (MS), according to the results of a phase two clinical trial to be presented as Emerging Science (formerly known ...
Neuroscience
Apr 16, 2012 |
3 / 5 (1) |
0